Alcresta Therapeutics

RELIZORB

Manufacturer:

Alcresta Therapeutics

Relizorb HCPCS:

B4105

HCPCS Code Descriptor:

In-line cartridge containing digestive enzyme(s) for enteral feeding, each

Category:

B Code

Relizorb NDCs:

62205-0000-20

Primary Type:

Enzyme Replacement Therapy

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Route Not Applicable

Relizorb CPT Codes:

Potential CPT administration codes for Relizorb can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

62205-0000-20

About Relizorb:

RELIZORB is an Enzyme Replacement Therapy drug manufactured by Alcresta Therapeutics and administered via the Route Not Applicable route of administration. The B Code: B4105 is aligned to the drug RELIZORB.

ACCESS PRICING AND MORE BY REGISTERING

B4105 Added Date:

January 1, 2019

B4105 Effective Date:

January 1, 2019

B4105 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Relizorb billing and coding information.
Relizorb patient assistance information can be found through Relizorb Support Services at the URL: http://www.relizorb.com/
RELIZORB prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for RELIZORB. Please check back in a few weeks.